<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6629194/results/search/drugs/results.xml">
  <result pre="recommended as acute and short-term prophylactic treatment. Recombinant C1-INH and" exact="icatibant" post="are licensed for the acute treatment of pediatric patients."/>
  <result pre="14 ). If pdC1-INH is not available, attenuated oral androgen" exact="danazol" post="5 mg/kg/day or 10 mL/kg solvent detergent plasma (SDP)"/>
  <result pre="plasma (SDP) can be administered ( 14 ). Prophylaxis with" exact="danazol" post="should start 5 days before and be continued for"/>
  <result pre="Plasma-derived C1-INH, recombinant C1-INH (for children above 12 years) and" exact="icatibant" post="(for children above 2 years) are licensed for the"/>
 </snippets>
</snippetsTree>
